National Health Investors (NYSE:NHI) Updates FY24 Earnings Guidance

National Health Investors (NYSE:NHI) updated its FY24 earnings guidance on Tuesday. The company provided EPS guidance of $4.43-$4.44 for the period, compared to the consensus EPS estimate of $4.52. National Health Investors also updated its FY 2024 guidance to 4.430-4.440 EPS.

National Health Investors Stock Performance

Shares of NHI traded up $0.81 during mid-day trading on Tuesday, hitting $76.73. The stock had a trading volume of 340,585 shares, compared to its average volume of 190,436. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.91. National Health Investors has a fifty-two week low of $49.25 and a fifty-two week high of $86.13. The company’s fifty day simple moving average is $80.53 and its two-hundred day simple moving average is $73.03. The company has a market cap of $3.33 billion, a PE ratio of 26.00, a PEG ratio of 5.09 and a beta of 1.05.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share for the quarter, missing analysts’ consensus estimates of $1.10 by ($0.29). National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The company had revenue of $84.97 million for the quarter, compared to analyst estimates of $64.95 million. During the same quarter in the previous year, the company posted $1.06 earnings per share. The firm’s revenue for the quarter was up 9.1% compared to the same quarter last year. On average, equities analysts expect that National Health Investors will post 4.48 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on NHI. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Bank of America started coverage on National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price on the stock. Truist Financial increased their price objective on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research report on Friday, August 30th. Finally, Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and raised their target price for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.